John F. Thero

Insider Reports History

Entity
Individual
Location
C/O Amarin Pharma, Inc., 1430 Route 6, Bedminster, NJ
Signature
/s/ David Gaiero, as attorney-in-fact for John F. Thero
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John F. Thero:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AMARIN CORP PLC\UK President and CEO, Director Ordinary Shares 3.25M $3.55M $1.09 Jul 30, 2021 Direct
Cyteir Therapeutics, Inc. Director Common Stock 22.8K $38.6K $1.69 Feb 8, 2024 Direct
AMARIN CORP PLC\UK President and CEO, Director Restricted Stock Units 13.5K Jul 30, 2021 Direct
CHIASMA, INC Director Stock Option (Right to Buy) 0 Aug 5, 2021 Direct
CinCor Pharma, Inc. Director Stock Option (Right to Buy) 0 Feb 24, 2023 Direct
Cyteir Therapeutics, Inc. Director Stock Option (Right to Buy) 0 Feb 8, 2024 Direct

Insider Reports Filed by John F. Thero

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CYT Cyteir Therapeutics, Inc. Feb 8, 2024 2 $21.7K 4 Feb 12, 2024 Director
CINC CinCor Pharma, Inc. Feb 24, 2023 2 $0 4 Feb 24, 2023 Director
CYT Cyteir Therapeutics, Inc. Feb 3, 2023 1 $0 4 Feb 7, 2023 Director
CYT Cyteir Therapeutics, Inc. May 10, 2022 1 $20K 4 May 12, 2022 Director
CYT Cyteir Therapeutics, Inc. Feb 4, 2022 1 $0 4 Feb 7, 2022 Director
CYT Cyteir Therapeutics, Inc. Feb 4, 2022 0 $0 3 Feb 7, 2022 Director
CINC CinCor Pharma, Inc. Jan 6, 2022 0 $0 3 Jan 6, 2022 Director
CHMA CHIASMA, INC Aug 5, 2021 6 $0 4 Aug 5, 2021 Director
AMRN AMARIN CORP PLC\UK Jul 30, 2021 7 -$43.9K 4 Aug 3, 2021 President and CEO, Director
AMRN AMARIN CORP PLC\UK Jun 30, 2021 7 -$47.5K 4 Jul 2, 2021 President and CEO, Director
AMRN AMARIN CORP PLC\UK May 28, 2021 7 -$48.1K 4 May 28, 2021 President and CEO, Director